Augmentation cystoplasty in neuropathic bladder.

OBJECTIVES: To look at the changing role of cystoplasty in the neuropathic population.

DESIGN: Retrospective case series.

SETTING: Single center over a 10-year period from 2004 to 2014.

PARTICIPANTS AND INTERVENTION: In 1995, the Princess Royal spinal injuries unit published the outcomes of 78 neuropathic patients who had undergone cystoplasty in the 10-year period from 1982 to 1992. [Singh G, Thomas DG. Enterocystoplasty in the neuropathic bladder. Neurourol Urodyn 1995; 14(1): 5-10.]. In this series, we review 51 consecutive patients undergoing the same operation over a 10-year period from 2004 to 2014 in the same single unit.

OUTCOME MEASURES: Demographic data were collected to include patient age, condition, and previous treatments. Pre- and post-operative details included sphincter insertions, renal function, continence rates, and complications.

RESULTS: Despite an increase in the number of patients seen at the unit, there were considerably fewer cystoplasty procedures performed in the current series (51 vs. 78 in the 1982-1992 series). There were also significantly fewer patients with spina bifida and fewer concomitant sphincter insertions in the latter series (eight patients vs. 52 in the 82/92 series). Nevertheless, similar outcomes are observed between the current and 1982-1992 series, with continence rates of 93.7 and 93.6%, respectively and low numbers of reported adverse events for both retrospective cohorts.

CONCLUSIONS: Cystoplasty remains a safe and effective option for the management of neuropathic bladder in a carefully selected group of patients.